|
Originally published In Press as doi:10.1074/jbc.M105967200 on September 4, 2001
J. Biol. Chem., Vol. 276, Issue 47, 44239-44246, November 23, 2001
Measles Virus Envelope Glycoproteins
Hetero-oligomerize in the Endoplasmic Reticulum*
Richard K.
Plemper ,
Anthea L.
Hammond, and
Roberto
Cattaneo
From the Molecular Medicine Program, Mayo Foundation,
Rochester, Minnesota 55905
Received for publication, June 27, 2001, and in revised form, September 4, 2001
 |
ABSTRACT |
The endoplasmic reticulum (ER) was
investigated as the initial oligomerization site for the envelope
glycoproteins H and F of measles virus (MV), a clinically relevant
member of the Paramyxoviridae family, and consequences of this
interaction for viral replication were studied. Both proteins were
tagged at their cytosolic tails with RRR and KKXX motifs,
respectively, resulting in their efficient retention in the ER.
Co-transfection of the retained constructs with transport competent MV
glycoproteins revealed a dominant negative effect on their biological
activity indicating intracellular complex formation and thus retention.
Pulse-chase analysis and co-immunoprecipitation
experiments demonstrated that this effect is based on
both homo- and hetero-oligomerization in the ER.
Recombinant viruses additionally expressing
ER-retained F showed an altered cytopathic phenotype accompanied
by greatly reduced particle release. Similar mutant viruses
additionally expressing ER-retained H could not be rescued indicating
an even greater negative effect of this protein on virus viability. Our
study suggests that both homo- and hetero-oligomerization of MV
glycoproteins occur in the ER and that these events are of significance
for early steps of particle assembly.
 |
INTRODUCTION |
Measles virus (MV)1 is a
negative-stranded RNA virus of the Paramyxoviridae family. Despite the
existence of an effective live attenuated vaccine based on the
MV-Edmonston strain (MV-Edm), MV remains among the 10 most potent
global pathogens, killing over 1 million children annually in countries
where vaccination is not routine (1).
The MV envelope consists of hemagglutinin (H) and fusion (F)
glycoproteins. Whereas H binds to the MV receptors CD46 (2, 3) and
signaling lymphocytic activation molecule (4, 5), F carries a
hydrophobic fusion peptide that mediates membrane fusion upon receptor
binding of H (6). MV H is thought to exist at the viral surface as a
tetramer consisting of a dimer of two covalently linked dimers (7),
whereas F is considered to trimerize. Upon synthesis as an
inactive precursor F0, the protein becomes proteolytically
activated in the trans-Golgi network by furin yielding a large
transmembrane F1 and a small F2 fragment.
The mechanism of MV-induced membrane fusion may involve
receptor-induced conformational changes in H and then F, pointing to a
dynamic interaction between these proteins. This was first supported
through studies showing that expression of H or hemagglutinin neuraminidase (HN) and F from the same paramyxovirus is necessary for
efficient fusion, inferring their type-specific interaction (8-10).
Furthermore, specific mutations in HN lead to loss of fusion (10-12),
and direct cell surface interactions between MV H and F (13) and human
parainfluenza virus 2 (HPIV-2) HN and F (14) have been demonstrated by
co-immunoprecipitation experiments.
Although compelling evidence for an interaction between H/HN and F
exists, it remains unclear at which stage of cellular processing this
occurs. Upon synthesis, both proteins are integrated into the
endoplasmic reticulum (ER) membrane. Because the ER possesses a high
density of molecular chaperones (15), the virus might exploit these for
the efficient formation of envelope glycoprotein complexes. Indeed,
evidence for an ER association between HPIV-2 and -3 HN and F has been
presented (16, 17). However, in these studies soluble derivatives of
the glycoproteins carrying KDEL sequences (18) were used, which may
show folding patterns distinct from the native transmembrane proteins.
In contrast, another study demonstrated that full-length simian virus 5 (SV5) and HPIV-3 HN and F proteins retained in the ER did not affect
transport of homotypic HN and F species (19). For these experiments,
the authors added RRRRR (20) and KKXX motifs (21) to the
cytosolic tails of HN and F, respectively. In several studies theses
retention motifs have proven to be valuable tools to study virus
assembly (22, 23) and the cell biology of secretory proteins (24, 25).
All studies following the interaction of paramyxovirus glycoproteins
retained in the ER so far were based on the fate of plasmid-encoded, transiently expressed glycoproteins. Therefore, the effect of intracellularly retained viral glycoproteins on productive complex assembly in the context of a viral infection is unclear. We show that
the H and F glycoproteins of MV interact in the ER and that this
interaction has consequences for viral replication. By examining the
influence of transiently expressed ER-retained F and H on transport of
their unmodified homologues, strong homotypic and heterotypic
interactions of MV glycoproteins in the ER were identified, which
significantly reduced their biological activity. During virus
infection, these interactions were found to be important for MV release
and cytopathicity, implicating the ER as a site of MV glycoprotein
complex formation.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture, Generation of MV Stocks, and Virus Growth
Kinetics--
Vero (African green monkey kidney), HT1080 (human bone
fibrosarcoma), and PA317 (mouse hybridoma) cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, penicillin, and streptomycin at 37 °C and 5%
CO2. Stably transfected HT1080 cells were grown in the
presence of 2.5 µg/ml puromycin and 293-3-46 helper cells (26) in 1.2 µg/ml geneticin. For transient transfection LipofectAMINE (Life
Technologies, Inc.) was used, and cells were analyzed 18-24 h
post-transfection.
To prepare virus stocks, Vero cells were infected at a multiplicity of
infection (m.o.i.) of 0.1 plaque-forming units (pfu)/cell and incubated
at 37 °C until particles were released by three freeze-thaw cycles.
Titers were determined by 50% tissue culture infective dose
(TCID50) titration on Vero cells according to the Spearman-Karber method (27).
For virus growth kinetics, Vero cells (4 × 105 per
time point) were infected with an m.o.i. of 0.03 pfu/cell and incubated at 37 °C. At the indicated time points, virus titers in cleared supernatants and freeze-thawed cell lysates were determined by TCID50 titration.
Plasmid Construction--
Parental plasmids for mutagenesis and
all experiments were pCG-HEdm and pCG-FEdm
encoding MV-Edm H and F under the control of the cytomegalovirus
promoter (28). Site-directed mutagenesis was performed using the quick
change system (Stratagene) and mutant constructs confirmed by DNA
sequencing and Western analysis. In all primer sequences altered or
added nucleotides are underlined.
Primers used to generate pCG-HEdm-ER were
5-CTTAGGGTGCAAGATCATCGATAATGCGACGTCGGCGCCGTTCACCACAACGAGACCGGATAAATGC
and to generate pCG-FEdm-ER were
5-CCTATGTAAGGTCGCTCAAGAGTAAGACTCATTAATGATCCTCTACAACTCTTG. If indicated, the sequence encoding the FLAG epitope (DYKDDDDK) was
inserted upstream of the MV-HEdm, MV-HEdm-ER,
and MV-FEdm stop codon for detection purposes. Primers used
were
5-CGGGAAGATGGAACCAATCGCAGAGACTACAAGGATGACGATGACAAGTAGGGCTGCTAGTGAACCAATCTC to generate MV-HEdm-CFLAG and
MV-HEdm-ER CFLAG and
5-CATCAAAATCCTATGTAAGGTCGCTCGACTACAAGGATGACGATGACAAGTGATCCTCTACAACTCTTGAAACAC to generate MV-FEdm-CFLAG. Biological activity
of all tagged proteins was unchanged when compared with the parental
versions in transient transfection.
To integrate HEdm-ER and FEdm-ER in a DNA copy
of the measles genome, p(+)MV (26), MluI, and
AatII restriction sites were introduced upstream and
downstream of the open reading frames adhering to the reported "rule
of six" requirement (29). Primers used for pCG-HEdm-ER
CFLAG were
5-CTTAGGGTGCAAGATCATCGATAACGCGTATGCGGCGTC GGCGCCGTTCACCACAAC to generate the MluI site and
5-GATGACAAGTAGGGCTGCTAGTGAACGACGTCACCAATCTCATGATGTCACCCAGAC to generate the AatII site. Primers used for
pCG-FEdm-ER were 5-CAGAACCCAGACCCCGGCCCAC
ACGCGTGCGCCCCCAACCCCCGACAACC to generate the
MluI site and
5-CCCTCTGGCCGAACAATATCGGTAGACGTCAAAAG GATCCACTAGTTCTAGAGTCG to generate the AatII site. The MluI
AatII fragments were ligated into MluI
AatII digested p(+)MPeGFPV and p(+)MHeGFPV plasmids carrying
GFP in post-P or post-H position (30), thereby replacing GFP. This
resulted in plasmids p(+)MV-(P)HEdm-ER and
p(+)MV-(P)FEdm-ER and plasmids
p(+)MV-(H)HEdm-ER and p(+)MV-(H)FEdm-ER.
Measles genomes containing the GFP gene in pre-N position and the
HEdm-ER-CFLAG or FEdm-ER
open reading frame in post-H position were generated by cloning the
GFP-containing SacII NotI fragment of p(+)MV-GFP (31) into SacII NotI-digested plasmids
p(+)MV-(H)HEdm-ER and p(+)MV-(H)FEdm-ER,
resulting in plasmids p(+)MV-GFP (H)HEdm-ER and p(+)MV-GFP
(H)FEdm-ER.
Western Analysis and Deglycosylation--
For Western analysis,
4 × 105 cells were transfected with 2.5 µg of
plasmid DNA or infected with an m.o.i. of 0.03 pfu/cell and incubated
at 37 °C. At the indicated times, cells were washed in
phosphate-buffered saline (PBS) and lysed for 10 min at 4 °C in
lysis buffer (50 mM Tris, pH 8.0; 62.5 mM EDTA;
0.4% deoxycholate; 1% Igepal (Sigma)) containing protease inhibitors
(Complete mix (Roche Molecular Biochemicals)) and 1 mM
phenylmethylsulfonyl fluoride (PMSF). Unless otherwise stated, 2.5 µg
of total protein (determined using the DC Protein-Assay Kit (Bio-Rad))
was mixed with urea buffer (200 mM Tris, pH 6.8; 8 M urea; 5% SDS; 0.1 mM EDTA; 0.03% bromphenol
blue; 1.5% dithiothreitol) for 25 min at 50 °C. For nonreducing
conditions, dithiothreitol was omitted. Samples were fractionated on
SDS-polyacrylamide gels, blotted to polyvinylidene difluoride membranes
(Millipore), probed with the indicated antibody, and analyzed by
enhanced chemiluminescence (Amersham Pharmacia Biotech). For
endoglycosidase H (Endo H) treatment, lysates were mixed with
denaturing buffer (final concentration 0.5% SDS; 1%
-mercaptoethanol) for 25 min at 50 °C and then with deglycosylation buffer (final concentration 50 mM sodium
citrate, pH 5.5) and 0.5 units of Endo H for 12 h at 37 °C.
Urea buffer was added and samples subjected to Western analysis.
Metabolic Labeling and Immunoprecipitation--
Transfected Vero
cells were incubated for 30 min in labeling medium lacking cysteine,
methionine, and ammonium sulfate and then labeled with 100 µCi/ml
[35S]methionine (Amersham Pharmacia Biotech) for 45 min
at 37 °C. Subsequently, cells were incubated in chase medium
containing 10% fetal calf serum at 37 °C for the indicated chase
periods. For direct immunoprecipitation, cells were lysed in
radioimmunoprecipitation assay buffer (10 mM Tris, pH 7.4;
1% deoxycholate; 1% Triton X-100; 0.1% SDS; 150 mM
sodium chloride) containing protease inhibitors and 1 mM
PMSF for 15 min at 4 °C and centrifuged for 25 min at 20,000 × g and 4 °C. Lysates were incubated with antibodies
directed against MV H (Chemicon) or the FLAG epitope (M2, Sigma) for 90 min at 4 °C and then immune complexes adsorbed to protein G-agarose (Life Technologies, Inc.) for 90 min at 4 °C. Precipitates were washed in lysis buffer, incubated in urea buffer for 25 min at 50 °C, and fractionated on SDS-polyacrylamide gels. Dried gels were
exposed to Biomax films (Eastman Kodak Co.).
Confocal Microscopy--
Transfected Vero cells (5 × 103 cells in chamber slides (Chamber Slides; Lab Tec)) were
fixed with methanol at 20 °C, washed with PBS, and permeabilized
with PBS containing 1% Triton X-100. After blocking with nonspecific
goat antiserum (Sigma), cells were incubated with antibodies specific
for MV H or F tails (32) and subsequently with Texas Red-coupled
anti-rabbit serum (Sigma). As ER marker, fluorescein
isothiocyanate-coupled concanavalin A (Molecular Probes) was added to
the secondary antibody. Cells were washed, fixed with ProLong Antifade
Kit (Molecular Probes), and analyzed with a Zeiss LSM 510 confocal microscope.
Sucrose Gradient Fractionation--
Transfected Vero cells
(2 × 106) were scraped in resuspension buffer (10 mM Tris, pH 7.4; 10 mM sodium chloride; 1%
Triton X-100; 0.5% sodium deoxycholate) containing protease inhibitors and 1 mM PMSF, and 600 µg of total protein was layered
onto a 10-26% sucrose gradient prepared in resuspension buffer
containing 0.1% Triton X-100. For control, proteins were treated with
0.5% SDS on ice prior to loading. Gradients were centrifuged in an SW41 rotor for 18 h at 38,000 rpm at 10 °C, and 10 equal
fractions were collected. Proteins were precipitated with
trichloroacetic acid, resuspended in urea buffer, and subjected to
Western analysis. The location of marker proteins catalase (240,000 kDa), aldolase (158,000 kDa), and bovine serum albumin (68,000 kDa)
(all Sigma) was determined by silver staining (Silver staining kit;
Bio-Rad) of SDS-polyacrylamide gels.
Syncytium Formation--
Unless otherwise stated, Vero cells
were co-transfected in duplicate with 1.0 µg each of plasmid DNA
encoding FEdm and HEdm or GFP for control, and
3.0 µg of FEdm-ER or HEdm-ER and incubated at
32 °C to prevent them from reaching over-confluency. The number of
syncytia in 20 representative fields of view was determined at the
indicated times.
Co-immunoprecipitation Experiments--
Cells were
co-transfected with 2.5 µg each of plasmid DNA encoding
FEdm and HEdm or the ER-retained versions.
Cells were washed in PBS, scraped in co-immunoprecipitation buffer (10 mM Hepes, pH 7.4; 50 mM sodium pyrophosphate;
50 mM sodium fluoride; 50 mM sodium chloride; 5 mM EDTA; 5 mM EGTA; 100 µM sodium
vanadate; 1% Triton X-100) containing protease inhibitors and 1 mM PMSF, and centrifuged for 25 min at 20,000 × g and 4 °C. Protein complexes were immunoprecipitated
from 300 µg of total protein using MV H-specific antibodies
(Chemicon). As internal standard, 5 µg of total protein was directly
mixed with urea buffer. After absorption of immune complexes to protein
G-agarose (Life Technologies, Inc.), samples were washed in buffer 1 (100 mM Tris, pH 7.6; 500 mM lithium chloride;
0.1% Triton X-100; 1 mM dithiothreitol) and then in buffer
2 (20 mM Hepes, pH 7.2; 2 mM EGTA; 10 mM magnesium chloride; 0.% Triton X-100; 1 mM
dithiothreitol), resuspended in urea buffer for 25 min at 50 °C, and
subjected to Western analysis using antibodies specific for F tail.
Rescue of Mutant Viral Particles--
Recombinant MV particles
were generated essentially as described (26). The helper cell line
293-3-46 stably expressing MV-N, MV-P, and T7-polymerase was
co-transfected by calcium phosphate precipitation (ProFection; Promega)
with plasmids encoding the MV genome and L polymerase. Helper cells
were overlaid on Vero cells 76 h post-transfection and incubated
until syncytia appeared or, for GFP-expressing viruses, fluorescence
was detectable. Infectious centers were passaged on fresh Vero cells.
The integrity of recombinant viruses was verified by reverse
transcriptase-polymerase chain reaction and DNA sequencing.
 |
RESULTS |
MV Glycoproteins Carrying ER Retention Signals at Their Cytosolic
Tails Are Stably Expressed and Accumulate in the ER--
To generate
ER-retained versions of full-length MV-Edm glycoproteins, a 5-amino
acid RRRRR sequence was added to the cytosolic amino terminus of
HEdm and a KSKTH sequence to the carboxyl terminus of
FEdm (Fig.
1A).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
MV glycoproteins carrying retention
signals are efficiently retained in the ER. A, scheme
of MV H and F glycoproteins showing the five amino acid extensions
added to the cytosolic amino and carboxyl terminus. B, pulse
chase analysis of HEdm-ER and unmodified HEdm
transiently expressed in Vero cells. Numbers indicate chase times in
minutes. C, endoglycosidase H (EndoH) treatment
and Western analysis of antigenic material shown in B,
180-min chase time. Co contains mock-transfected cell
lysates for control. res, resistant; sens,
sensitive. D, Western analysis of FEdm and
FEdm-ER transfected Vero cells. E and
F, confocal analysis of HEdm and
HEdm-ER 30 h post-transfection and of FEdm
and FEdm-ER 40 h post-transfection. For general ER
staining, fluorescein isothiocyanate-labeled concanavalin A
(ConA) was used.
|
|
Expression and stability first of HEdm-ER was assessed by
transient expression in Vero cells and pulse-chase analysis (Fig. 1B). Whereas the stability of HEdm-ER was
similar to that observed for HEdm, HEdm-ER
lacked the Golgi-specific conversion from core to complex
N-linked oligosaccharide chains characterized by an ~4 kDa
increase in molecular mass over time (33), suggesting its
inhibited export from the ER. This was further assessed by treating the
samples corresponding to 180-min chase time with endoglycosidase H
(Endo H) prior to immunoblotting (Fig. 1C). All of the
HEdm-ER material was sensitive to Endo H treatment, supporting its efficient retention in the ER.
Because most oligosaccharides on F0 are highly sensitive to
Endo H (34), Endo H resistance cannot be used to monitor its ER export.
Instead, processing of MV F from F0 to F1,
mediated by furin in late Golgi compartments (35), was assessed after transient transfection of Vero cells; most unmodified FEdm
was proteolytically activated, but no antigenic material corresponding to an F1 fraction could be detected for FEdm-ER
supporting its ER localization (Fig. 1D).
To investigate further the ER retention of HEdm-ER and
FEdm-ER, their co-localization with an ER-specific lectin,
concanavalin (Con) A, was compared with that of the unmodified parental
proteins by confocal microscopy (Fig. 1, E and
F). Localization of HEdm-ER overlapped almost
exclusively with ConA staining, confirming the ER retention of the
HEdm-ER protein. In cells expressing HEdm, however, only some overlap with Con A staining was observed
corresponding to the normal steady state level of HEdm in
the ER.
Slightly greater co-staining of FEdm with ConA was observed
(Fig. 1F), presumably reflecting a slightly higher steady
state level of transport-competent FEdm than
HEdm in the ER. In cells expressing FEdm-ER,
however, almost complete co-localization with ConA was observed,
confirming its ER retention.
Homo-oligomerization Capacity of ER-localized MV Proteins Is
Unchanged--
To analyze whether the presence of the ER retention
signals influences native folding of HEdm-ER and
FEdm-ER, their ability to homo-oligomerize was monitored.
Covalently linked H-H homodimers were detected by separation of
transiently expressed material under reducing and nonreducing
conditions (Fig. 2A). Both
HEdm and HEdm-ER migrated exclusively as dimers
under nonreducing conditions, whereas treatment of cell lysates with
1.5% dithiothreitol resulted in migration of both variants as
monomers.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
ER-retained MV glycoproteins homo-oligomerize
as efficiently as the unmodified proteins. A, Western
analysis of Vero cells expressing HEdm and
HEdm-ER under reducing (1.5% DTT) and
nonreducing (- -) conditions. Numbers correspond to the molecular
weight of protein standard (in thousands). B, sucrose
gradient centrifugation and Western analysis of FEdm and FEdm-ER in the
presence and absence of 0.5% SDS. Lys contains 1 µg of total protein
lysates for comparison. Ten gradient fractions from top (1)
to bottom (10) are loaded. The positions of marker proteins
bovine serum albumin (BSA), aldolase (Ald), and
catalase (Cat) separated on independent gradients are
indicated.
|
|
Because MV F protein is thought to exist as a noncovalently linked
trimer, sucrose gradient fractionation of FEdm-ER or
FEdm proteins was employed to detect oligomeric versions
(Fig. 2B). The majority of unmodified F0 was
found in fraction 5 corresponding to the molecular weight of an F
trimer as determined by comparison with molecular weight marker
proteins. Cleavage of F0 into F1 seemed to
reduce the stability of the trimers because an increasing amount of
F1 material was found in earlier fractions of the gradient corresponding to monomeric F protein. FEdm-ER was not
proteolytically processed, and its F0 form was
predominantly found in fraction 5, although some antigenic material
corresponding to higher order complexes could be detected. Treatment of
both FEdm and FEdm-ER with 0.5% SDS resulted
in a shift of protein to the monomeric form sedimenting in fraction 3 of the gradient because of destruction of noncovalent complexes. Thus,
F and H homo-oligomerization capacities are unchanged by their ER retention.
Intracellularly Retained MV Glycoproteins Reduce Transport Kinetics
of Their Unmodified Homologues--
We assessed the biological
consequence of the ER localization of FEdm-ER and
HEdm-ER by studying their effect on syncytium induction
mediated by unmodified MV H and F when transiently co-expressed in Vero
cells (Fig. 3A).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
HEdm-ER and FEdm-ER
have a dominant negative effect on the biological activity of
unmodified MV glycoproteins. A, kinetics of syncytium
formation following transfection of Vero cells with 1 µg of plasmid
DNA encoding HEdm, FEdm, and a 3-fold excess of
either HEdm-ER or FEdm-ER. For comparison,
cells transfected only with HEdm and FEdm,
HEdm-ER and FEdm, or FEdm-ER and
HEdm are shown. Columns reflect the average number of
syncytia scored in three independent experiments. 4000 syncytia per
well represent complete lysis which precluded further counting.
B, representative fields of view of cells 20 h
post-transfection with 0.5 µg of plasmid DNA encoding
HEdm and FEdm and with a 5-fold excess of
either HEdm-ER or FEdm-ER. For control, cells
transfected with HEdm and FEdm only and
mock-transfected cells (Co) are shown. C and
D, Western analysis of total cell lysates derived from
B using MV F- (C) or MV H-specific (D)
antibodies. Antigenic material shown in D was subjected to
Endo H treatment as indicated.
|
|
Expression of either HEdm-ER with unmodified
FEdm or, reciprocally, FEdm-ER with unmodified
HEdm resulted in minimal syncytium formation, consistent
with efficient intracellular retention of HEdm-ER and
FEdm-ER. Expression of both unmodified HEdm and
FEdm with a 3-fold excess of HEdm-ER resulted
in a dominant negative effect on syncytium formation, with a delay in
development of cytopathic effects. Expression of FEdm-ER
with unmodified HEdm and FEdm also delayed the
onset of syncytia but to a lesser degree than that observed with
HEdm-ER. This difference is probably because of the
covalent and therefore more stable dimerization of MV H in comparison
to the noncovalent homo-oligomerization observed for MV F.
By using a 5-fold excess of the ER-retained constructs to establish
more stringent retention of the unmodified proteins, only very few
isolated syncytia could be detected in contrast to the massive
formation of syncytia in cells expressing the unmodified proteins alone
(Fig. 3B). Subsequent Western analysis of cell lysates
revealed that in the presence of FEdm-ER, proteolytic processing of FEdm to F1 was strongly
inhibited, whereas in its absence, FEdm was efficiently
processed to F1 indicating transport to post-ER
compartments (Fig. 3C).
Similarly, in the cells co-expressing HEdm-ER (Fig.
3D), HEdm showed a strongly reduced rate of
Golgi-type carbohydrate chain trimming, indicated by its nearly
complete sensitivity to Endo H treatment. In the absence of
HEdm-ER however, ~50% of HEdm was found to
be resistant to Endo H treatment. Thus, both FEdm and HEdm are strongly retained in the ER in the presence of
FEdm-ER and HEdm-ER, respectively.
Efficient Hetero-oligomerization of MV Glycoproteins Occurs in the
ER--
To address whether hetero-oligomerization of the ER-retained
glycoproteins with their unmodified counterparts also contributes to
the dominant negative phenotype, their influence on transport kinetics
of HEdm and FEdm was investigated by
pulse-chase analysis (Fig. 4,
A and B). FLAG epitope-tagged versions of
HEdm and FEdm proteins were used for these
experiments to achieve identical immunoprecipitation conditions.
Transport kinetics of the tagged glycoproteins were shown not to be
influenced by the FLAG epitope itself (Ref. 7 and data not shown).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
MV H and F proteins form complexes in the ER.
A and B, pulse chase analysis of Vero cells
transfected with equal amounts of HEdm and FEdm
or FEdm-ER (A) or FEdm and
HEdm or HEdm-ER (B). Numbers
correspond to chase times in minutes. FLAG epitope-tagged versions of
HEdm (A) and FEdm (B)
were transfected, and immunoprecipitation was carried out using
antibodies directed against the FLAG epitope. Quantifications are based
on either the increase in Golgi-type carbohydrate chains (A)
or the decrease in intensity of the F0 fractions
(B). C, co-immunoprecipitation of
FEdm or FEdm-ER with either HEdm or
HEdm-ER using antibodies directed against MV H followed by
Western analysis of MV F. Lanes marked IP contain material
co-precipitated from 100 µg of total cell lysate, whereas total cell
lysates (TL) indicate direct loading of 1 µg of total
lysate without prior immunoprecipitation. Cells transfected with
FEdm or HEdm alone were analyzed for control.
Numbers indicate the relative percentage of precipitated
material in relation to the total lysate. In case of unmodified
proteins H and F, the sum derived from both F fractions, F0
and F1, was used for quantification.
|
|
In the presence of equivalent amounts of HEdm and
FEdm-ER, kinetics of carbohydrate chain conversion of
HEdm to the Golgi-specific pattern was significantly
reduced, with far less than 50% conversion after 180 min (Fig.
4A). In contrast, when co-expressed with FEdm, 50% carbohydrate chain conversion of HEdm was observed
after less than 120 min. When the reciprocal analysis of
FEdm transport was carried out, FEdm was
processed efficiently, with furin cleavage ~75% complete by 120 min
in the presence of unmodified HEdm (Fig. 4B).
After co-expression with HEdm-ER, however, processing to F1 was less than 30% complete after 120-min chase time.
Thus, both HEdm and FEdm are significantly
retained in the ER because of a heterotypic interaction with
HEdm-ER and FEdm-ER, respectively. Interestingly, the amount of metabolically labeled FEdm
immunoprecipitated in the presence of HEdm-ER was
consistently reduced compared with that in cells co-expressing
HEdm. Conceivably, this reflects a slightly reduced
FEdm protein expression level in the presence of
HEdm-ER.
To assess hetero-oligomerization of MV glycoproteins in the ER by a
more direct biochemical approach, we followed the interaction of
FEdm or FEdm-ER with HEdm or
HEdm-ER by co-immunoprecipitation of MV F with H, using
anti-F antibodies for detection by Western analysis (Fig.
4C). The relative efficiency of co-precipitation was
determined for each sample by comparison with directly loaded total
cell lysates. FEdm-ER not only co-precipitated with
HEdm, but this interaction was significantly more efficient
than that of the unmodified parental proteins FEdm with
HEdm. Similarly, the reciprocal co-immunoprecipitation of
FEdm with HEdm-ER was substantially more
efficient than that of FEdm with HEdm (Fig. 4C). For control, cells were co-transfected with both
ER-retained glycoproteins; as expected very efficient co-precipitation
was observed under these conditions. Thus, the dominant negative effect of the ER-retained species on syncytium formation is attributable to
both homotypic interaction of FEdm-ER with FEdm
or HEdm-ER with HEdm and heterotypic
oligomerization of FEdm-ER trimers with HEdm or
HEdm-ER complexes with FEdm.
Mutant MV Additionally Expressing FEdm-ER Shows Reduced
Cytopathicity and Release--
To address the interference function of
HEdm-ER, which displayed the stronger negative effect on
syncytium formation, in a viral infection, an MV-susceptible HT1080
cell line stably expressing HEdm-ER was generated. When
infected with MV-Edm, however, generation of cell-associated infectious
MV particles was unaffected, although release of virus was reduced at
early time points (data not shown). Assessing the relative levels of
nuclear and virally encoded H proteins demonstrated that the virus
overcomes any inhibitory effects of HEdm-ER by producing a
vast excess of virally encoded HEdm.
To express ER-retained glycoproteins at higher levels in the context of
a viral infection, the genes encoding HEdm-ER and FEdm-ER were thus inserted as additional transcription
units downstream of either P or H in a positive strand copy of the MV
genome (Fig. 5A). Because of a
transcription gradient described for MV, levels of gene expression from
the P position are about three times higher than from the H position
(36). In repeated attempts none of these recombinant MVs could be
recovered, whereas parallel rescues of unmodified MV-Edm were
successful (data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 5.
Virally encoded ER-retained MV glycoproteins
alter the cytopathic effect and viral spread. A, scheme of
recombinant MV plasmids containing HEdm-ER or
FEdm-ER additional transcription units. The position of the
GFP gene in the MV genome in constructs
p(+)MV-GFP(H)HEdm-ER and p(+)MV-GFP(H)HEdm-ER
is indicated. B, spread of mutant viral particles in tissue
culture followed by the appearance of green fluorescence. Vero cells
were infected with newly rescued viral particles and incubated at
37 °C. C, growth kinetics of MV-GFP and
MV-GFP(H)FEdm-ER in Vero cells. Cells were infected with an
m.o.i. of 0.03 pfu/cells. Plotted are titers determined in three
independent experiments for both cell associated and released viral
particles. D-F, Western analysis of cell culture
supernatant (D) and total cell lysates (E and
F) derived from Vero cells infected with MV-GFP and
MV-GFP(H)FEdm-ER at the indicated time points
postinfection. Equal volumes of supernatant or equal amounts of total
protein were loaded on the gels. D and E, MV F
specific antibodies were used for detection. Antigenic material in
F analyzed with MV H-specific antiserum was subjected to
Endo H treatment as indicated.
|
|
To facilitate detection of infection, full-length genomes carrying GFP
in addition to HEdm-ER and FEdm-ER in post-H
position were generated (Fig. 5A). Whereas MV-GFP
(H)HEdm-ER could not be rescued, MV-GFP
(H)FEdm-ER was recovered, and the integrity of the insert
in the viral genome was confirmed for several independent clones by
reverse transcriptase-polymerase chain reaction and DNA sequencing
(data not shown). When a single infectious center of either MV-GFP
(H)FEdm-ER or MV-GFP was transferred to Vero cells, MV-GFP
spread completely through the cell monolayer by 5 days post-infection
(Fig. 5B). In contrast, MV-GFP (H)FEdm-ER demonstrated a greatly reduced lateral spread characterized by the
formation of very few defined syncytia even 7 days post-infection.
Release of MV-GFP (H)FEdm-ER particles into the medium was
greatly delayed in comparison with MV-GFP, with ~100-fold less particles released at 48-56 h post-infection (Fig. 5C).
This finding mirrored our previous observation of delayed particle
release from HT1080 HEdm-ER cells. Consistent with the
viral growth curve, barely detectable levels of F1 in
released MV-GFP (H)FEdm-ER particles were found 64 h
post-infection, whereas F1 incorporated into MV-GFP was
detected 48 h post-infection (Fig. 5D). In
MV-GFP-infected cells, F1 was detected 40 h
post-infection, and the F1 signal was stronger than the
F0 signal (Fig. 5E), a pattern of F expression consistent in MV infections. In MV-GFP (H)FEdm-ER-infected
cells, however, appearance of F1 was greatly delayed as
compared with F0, with a faint F1 band visible
only after 48 h (Fig. 5E). In contrast, ER export of MV
H, as measured by conversion from core to Golgi-specific complex
N-linked oligosaccharide chains, was only slightly reduced
(Fig. 5F), suggesting a stronger homotypic interaction in
the context of this virus. Thus, in the presence of virally encoded
FEdm-ER protein, transport of MV F and release of viral
particles are significantly impaired resulting in a diminished cytopathic effect.
 |
DISCUSSION |
Our study demonstrates that ER-localized MV H and F proteins
interfere with the ER export of their unmodified homologues via both
homo- and hetero-oligomerization. Importantly, ER retention of H and F
has biological consequences, not only diminishing their ability to
induce cell-cell fusion upon transient expression but also reducing
particle release in the context of a viral infection.
Although a concern of our approach may be that ER retention of MV H and
F results in formation of non-native multimers,the demonstration
that both proteins are able to homo-oligomerize efficiently suggests
that this is not the case. Furthermore, that ER-retained SV5 and HPIV-3
HN and F carrying similar retention signals do not interact with their
unmodified counterparts (19) suggests that our contrasting findings are
not a general consequence of the approach but rather reflect a specific
property of MV glycoprotein complex formation.
Given the native conformation of our ER-retained MV glycoproteins and
their inhibitory effect on biological activity of unmodified H and F
through both homo- and hetero-oligomerization when transiently expressed, it was feasible to assess their impact on virus replication. When ER-retained and nonretained glycoproteins were both virally encoded, the retained proteins apparently had a strong negative effect
on virus viability. Several recombinant MV genomes were constructed,
but only that expressing the protein least efficient in ER retention,
FEdm-ER, at the lowest level could be recovered and
propagated. In MV-GFP (H)FEdm-ER infected cells release of viral particles was severely impaired, and secondary infections were
greatly reduced, resulting in a delay of viral spread through a cell
monolayer. Consistent with this, processing of F0 to
F1 was markedly delayed, suggesting ER retention of the
virus-encoded unmodified F protein. This delay was not mirrored when
following cell-associated infectious titer, possibly reflecting
activation by furin cleavage of the ER-retained particles during the
harvesting process. Although our transient expression data demonstrate
both homo- and hetero-oligomerization of MV H and F in the ER, ER
export of H in MV-GFP (H)FEdm-ER-infected cells was not
significantly delayed. Thus under these conditions
hetero-oligomerization of HEdm with FEdm-ER
cannot be observed, possibly because of a combination of stronger
homotypic than heterotypic interaction in the ER and a lower expression
level of FEdm-ER compared with unmodified F. The
recombinant particles in which this ratio is reversed, however, could
not be rescued.
In contrast to our findings, ER-retained HN and F proteins of the
related SV5 and human parainfluenza virus type 3 (HPIV-3) do not
interact with their unmodified homologues when transiently expressed
(19). For these paramyxoviruses, it is therefore likely that HN and F
interact functionally only at the cell surface, a strategy that may
prevent fusion in inappropriate cellular compartments after furin
cleavage. That MV H and F proteins do interact in the ER suggests MV
must either adopt a different mechanism to prevent premature fusion or
must not require such a strategy at all. It is intriguing to speculate
that distinct entry mechanisms for different paramyxoviruses may confer
virus-specific requirements for fusion regulation. The receptor for
both SV5 and HPIV-3, and all paramyxoviridae with neuraminidase
activity, is the abundant ganglioside sialic acid (37, 38). In
contrast, MV uses a specific protein, either CD46 or signaling
lymphocytic activation molecule as a receptor (2-4). These proteins
may be less available for early fusion than sialic acid, rendering the
problem of inappropriate intracellular less pronounced for MV.
In conclusion, the data obtained in our study show that MV H and F
glycoprotein oligomers associate in the ER and that this interaction
has relevance for efficient virus replication. Thus, the ER may be
considered an assembly site of functional MV glycoprotein complexes.
Although we have not observed any escape mutants of the virus
expressing FEdm-ER so far, it is intriguing whether extended passaging results in the appearance of such mutants with altered glycoprotein complex stability. Analysis of these mutations may
allow further insight into requirements for the interaction of H and F
and thus into the earliest steps of MV particle assembly.
 |
ACKNOWLEDGEMENTS |
We thank L. Hangartner and M. Billeter for
providing plasmids encoding full-length MV genomes, B. Fuchs and S. Vongpunsawad for assistance, and A. Fielding for critical reading of
the manuscript.
 |
FOOTNOTES |
*
This work was supported by grants from the Siebens and Mayo
Foundations (to R. C.), the Fraternity of the Eagles (to R. K. P.),
and an Emmy-Noether postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (to R. K. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Molecular Medicine
Program, Mayo Foundation, 200 1st St. SW, Rochester, MN 55905. Tel.:
507-538-1105; Fax: 507-284-8388; E-mail:
plemper.richard@mayo.edu.
Published, JBC Papers in Press, September 4, 2001, DOI 10.1074/jbc.M105967200
 |
ABBREVIATIONS |
The abbreviations used are:
MV, measles virus;
MV-Edm, MV-Edmonston strain;
H, hemagglutinin;
F, fusion;
HN, hemagglutinin neuraminidase;
HPIV, human parainfluenza virus;
ER, endoplasmic reticulum;
m.o.i., multiplicity of infection;
pfu, plaque-forming units;
GFP, green fluorescent protein;
PBS, phosphate-buffered saline;
PMSF, phenylmethylsulfonyl fluoride;
Endo H, endoglycosidase H;
SV5, simian virus 5.
 |
REFERENCES |
| 1.
|
Murray, C. J.,
and Lopez, A. D.
(1997)
Lancet
349,
1269-1276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Naniche, D.,
Varior-Krishnan, G.,
Cervoni, F.,
Wild, T. F.,
Rossi, B.,
Rabourdin-Combe, C.,
and Gerlier, D.
(1993)
J. Virol.
67,
6025-6032[Abstract/Free Full Text]
|
| 3.
|
Dorig, R. E.,
Marcil, A.,
Chopra, A.,
and Richardson, C. D.
(1993)
Cell
75,
295-305[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Tatsuo, H.,
Ono, N.,
Tanaka, K.,
and Yanagi, Y.
(2000)
Nature
406,
893-897[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hsu, E. C.,
Iorio, C.,
Sarangi, F.,
Khine, A. A.,
and Richardson, C. D.
(2001)
Virology
279,
9-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Richardson, C.,
Hull, D.,
Greer, P.,
Hasel, K.,
Berkovich, A.,
Englund, G.,
Bellini, W.,
Rima, B.,
and Lazzarini, R.
(1986)
Virology
155,
508-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Plemper, R. K.,
Hammond, A. L.,
and Cattaneo, R.
(2000)
J. Virol.
74,
6485-6493[Abstract/Free Full Text]
|
| 8.
|
Horvath, C. M.,
Paterson, R. G.,
Shaughnessy, M. A.,
Wood, R.,
and Lamb, R. A.
(1992)
J. Virol.
66,
4564-4569[Abstract/Free Full Text]
|
| 9.
|
Hu, X. L.,
Ray, R.,
and Compans, R. W.
(1992)
J. Virol.
66,
1528-1534[Abstract/Free Full Text]
|
| 10.
|
Tsurudome, M.,
Kawano, M.,
Yuasa, T.,
Tabata, N.,
Nishio, M.,
Komada, H.,
and Ito, Y.
(1995)
Virology
213,
190-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Deng, R.,
Wang, Z.,
Mirza, A. M.,
and Iorio, R. M.
(1995)
Virology
209,
457-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Tanabayashi, K.,
and Compans, R. W.
(1996)
J. Virol.
70,
6112-6118[Abstract]
|
| 13.
|
Malvoisin, E.,
and Wild, T. F.
(1993)
J. Gen. Virol.
74,
2365-2372[Abstract/Free Full Text]
|
| 14.
|
Yao, Q.,
Hu, X.,
and Compans, R. W.
(1997)
J. Virol.
71,
650-656[Abstract]
|
| 15.
|
Ellgaard, L.,
Molinari, M.,
and Helenius, A.
(1999)
Science
286,
1882-1888[Abstract/Free Full Text]
|
| 16.
|
Tanaka, Y.,
Heminway, B. R.,
and Galinski, M. S.
(1996)
J. Virol.
70,
5005-5015[Abstract/Free Full Text]
|
| 17.
|
Tong, S.,
and Compans, R. W.
(1999)
J. Gen. Virol.
80,
107-115[Abstract]
|
| 18.
|
Munro, S.,
and Pelham, H. R.
(1987)
Cell
48,
899-907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Paterson, R. G.,
Johnson, M. L.,
and Lamb, R. A.
(1997)
Virology
237,
1-9[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Schutze, M. P.,
Peterson, P. A.,
and Jackson, M. R.
(1994)
EMBO J.
13,
1696-1705[Medline]
[Order article via Infotrieve]
|
| 21.
|
Jackson, M. R.,
Nilsson, T.,
and Peterson, P. A.
(1990)
EMBO J.
9,
3153-3162[Medline]
[Order article via Infotrieve]
|
| 22.
|
Salzwedel, K.,
West, J. T., Jr.,
Mulligan, M. J.,
and Hunter, E.
(1998)
J. Virol.
72,
7523-7531[Abstract/Free Full Text]
|
| 23.
|
Browne, H.,
Bell, S.,
Minson, T.,
and Wilson, D. W.
(1996)
J. Virol.
70,
4311-4316[Abstract]
|
| 24.
|
Johannes, L.,
and Goud, B.
(1998)
Trends Cell Biol.
8,
158-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Maltese, W. A.,
Wilson, S.,
Tan, Y.,
Suomensaari, S.,
Sinha, S.,
Barbour, R.,
and McConlogue, L.
(2001)
J. Biol. Chem.
276,
20267-20279[Abstract/Free Full Text]
|
| 26.
|
Radecke, F.,
Spielhofer, P.,
Schneider, H.,
Kaelin, K.,
Huber, M.,
Dotsch, C.,
Christiansen, G.,
and Billeter, M. A.
(1995)
EMBO J.
14,
5773-5784[Medline]
[Order article via Infotrieve]
|
| 27.
|
Kado, G.
(1976)
Dev. Biol. Stand.
37,
261-264[Medline]
[Order article via Infotrieve]
|
| 28.
|
Cathomen, T.,
Buchholz, C. J.,
Spielhofer, P.,
and Cattaneo, R.
(1995)
Virology
214,
628-632[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Calain, P.,
and Roux, L.
(1993)
J. Virol.
67,
4822-4830[Abstract/Free Full Text]
|
| 30.
|
Wang, Z.,
Hangartner, L.,
Cornu, T. I.,
Martin, L. R.,
Zuniga, A.,
Billeter, M. A.,
and Naim, H. Y.
(2001)
Vaccine
19,
2329-2336[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Duprex, W. P.,
McQuaid, S.,
Hangartner, L.,
Billeter, M. A.,
and Rima, B. K.
(1999)
J. Virol.
73,
9568-9575[Abstract/Free Full Text]
|
| 32.
|
Cathomen, T.,
Naim, H. Y.,
and Cattaneo, R.
(1998)
J. Virol.
72,
1224-1234[Abstract/Free Full Text]
|
| 33.
|
Ogura, H.,
Sato, H.,
Kamiya, S.,
and Nakamura, S.
(1991)
J. Gen. Virol.
72,
2679-2684[Abstract/Free Full Text]
|
| 34.
|
Hu, A.,
Cathomen, T.,
Cattaneo, R.,
and Norrby, E.
(1995)
J. Gen. Virol.
76,
705-710[Abstract/Free Full Text]
|
| 35.
|
Bolt, G.,
and Pedersen, I. R.
(1998)
Virology
252,
387-398[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Cattaneo, R.,
Rebmann, G.,
Schmid, A.,
Baczko, K.,
ter Meulen, V.,
and Billeter, M. A.
(1987)
EMBO J.
6,
681-688[Medline]
[Order article via Infotrieve]
|
| 37.
|
Markwell, M. A.,
and Paulson, J. C.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
5693-5697[Abstract/Free Full Text]
|
| 38.
|
Suzuki, T.,
Portner, A.,
Scroggs, R. A.,
Uchikawa, M.,
Koyama, N.,
Matsuo, K.,
Suzuki, Y.,
and Takimoto, T.
(2001)
J. Virol.
75,
4604-4613[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. D. Muhlebach, V. H. J. Leonard, and R. Cattaneo
The Measles Virus Fusion Protein Transmembrane Region Modulates Availability of an Active Glycoprotein Complex and Fusion Efficiency
J. Virol.,
November 15, 2008;
82(22):
11437 - 11445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Lee, A. Prussia, T. Paal, L. K. White, J. P. Snyder, and R. K. Plemper
Functional Interaction between Paramyxovirus Fusion and Attachment Proteins
J. Biol. Chem.,
June 13, 2008;
283(24):
16561 - 16572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Plattet, P. Cherpillod, D. Wiener, L. Zipperle, M. Vandevelde, R. Wittek, and A. Zurbriggen
Signal Peptide and Helical Bundle Domains of Virulent Canine Distemper Virus Fusion Protein Restrict Fusogenicity
J. Virol.,
October 15, 2007;
81(20):
11413 - 11425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Corey and R. M. Iorio
Mutations in the Stalk of the Measles Virus Hemagglutinin Protein Decrease Fusion but Do Not Interfere with Virus-Specific Interaction with the Homologous Fusion Protein
J. Virol.,
September 15, 2007;
81(18):
9900 - 9910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Lee, A. Prussia, J. P. Snyder, and R. K. Plemper
Reversible Inhibition of the Fusion Activity of Measles Virus F Protein by an Engineered Intersubunit Disulfide Bridge
J. Virol.,
August 15, 2007;
81(16):
8821 - 8826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. McGinnes and T. G. Morrison
Inhibition of Receptor Binding Stabilizes Newcastle Disease Virus HN and F Protein-Containing Complexes
J. Virol.,
March 15, 2006;
80(6):
2894 - 2903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Doyle, A. Prussia, L. K. White, A. Sun, D. C. Liotta, J. P. Snyder, R. W. Compans, and R. K. Plemper
Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein
J. Virol.,
February 1, 2006;
80(3):
1524 - 1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Plemper, J. Doyle, A. Sun, A. Prussia, L.-T. Cheng, P. A. Rota, D. C. Liotta, J. P. Snyder, and R. W. Compans
Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains
Antimicrob. Agents Chemother.,
September 1, 2005;
49(9):
3755 - 3761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Welstead, E. C. Hsu, C. Iorio, S. Bolotin, and C. D. Richardson
Mechanism of CD150 (SLAM) Down Regulation from the Host Cell Surface by Measles Virus Hemagglutinin Protein
J. Virol.,
September 15, 2004;
78(18):
9666 - 9674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Hengst and J. S. Bond
Transport of Meprin Subunits through the Secretory Pathway: ROLE OF THE TRANSMEMBRANE AND CYTOPLASMIC DOMAINS AND OLIGOMERIZATION
J. Biol. Chem.,
August 13, 2004;
279(33):
34856 - 34864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Plemper, K. J. Erlandson, A. S. Lakdawala, A. Sun, A. Prussia, J. Boonsombat, E. Aki-Sener, I. Yalcin, I. Yildiz, O. Temiz-Arpaci, et al.
A target site for template-based design of measles virus entry inhibitors
PNAS,
April 13, 2004;
101(15):
5628 - 5633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Ding, S.-J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation
J. Virol.,
October 15, 2003;
77(20):
11027 - 11039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. von Messling and R. Cattaneo
N-Linked Glycans with Similar Location in the Fusion Protein Head Modulate Paramyxovirus Fusion
J. Virol.,
October 1, 2003;
77(19):
10202 - 10212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Chazal and D. Gerlier
Virus Entry, Assembly, Budding, and Membrane Rafts
Microbiol. Mol. Biol. Rev.,
June 1, 2003;
67(2):
226 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Plemper and R. W. Compans
Mutations in the Putative HR-C Region of the Measles Virus F2 Glycoprotein Modulate Syncytium Formation
J. Virol.,
April 1, 2003;
77(7):
4181 - 4190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Bossart, L.-F. Wang, M. N. Flora, K. B. Chua, S. K. Lam, B. T. Eaton, and C. C. Broder
Membrane Fusion Tropism and Heterotypic Functional Activities of the Nipah Virus and Hendra Virus Envelope Glycoproteins
J. Virol.,
October 11, 2002;
76(22):
11186 - 11198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. von Messling and R. Cattaneo
Amino-Terminal Precursor Sequence Modulates Canine Distemper Virus Fusion Protein Function
J. Virol.,
March 27, 2002;
76(9):
4172 - 4180.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|